The Effect of Exogenous Surfactant on Moderate and Severe Stages of COVID-19 Induced ARDS: the Pilot Study of a Clinical Trial.
ARDS
COVID-19
Pulmonary involvement
Surfactant
Journal
Iranian journal of pharmaceutical research : IJPR
ISSN: 1735-0328
Titre abrégé: Iran J Pharm Res
Pays: Netherlands
ID NLM: 101208407
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
14
12
2021
pubmed:
15
12
2021
medline:
15
12
2021
Statut:
ppublish
Résumé
COVID-19 pandemic has created a global health challenge. Many pharmaceuticals have been repurposed as potential treatments, though many have not been promising. Due to the inflammatory and destructive effects of the virus on alveolar cells, the effect of exogenous surfactant was assessed as a potential treatment of lung dysfunction in COVID-19 patients. In this pilot study of the clinical trial, 49 patients aged 35-80 years with COVID-19 admitted in ICU entered the study (22 patients intubated and 23 had face masks; 4 patients in the control arm). The treatment arm patients received two consecutive doses of surfactant. P/F ratio (based on serial blood gas analyses before and 12 hours after 2 doses of surfactant) and also, clinical outcomes were assessed.in COVID-19 adult patients, surfactant significantly improved pulmonary P/F ratio both in intubated and face mask COVID-19 patients (increasing from 119.2 ± 51.7 to 179.4 ± 115.5). The rate of extubation was much better than similar country-wide studies. Surfactant significantly alleviates the respiratory status in moderate to severe COVID-19 ARDS with two consecutive 100 mg doses of surfactant (with 6 hours' interval) though previous studies have been controversial, regarding the effect of surfactant in general forms of ARDS. Higher doses might have better effects, mandating more trials.
Identifiants
pubmed: 34904008
doi: 10.22037/ijpr.2021.115390.15347
pmc: PMC8653667
doi:
Types de publication
Journal Article
Langues
eng
Pagination
553-559Références
J Intensive Care Med. 2006 May-Jun;21(3):119-43
pubmed: 16672636
Curr Opin Crit Care. 2013 Feb;19(1):16-23
pubmed: 23235543
Chest. 2020 Jun;157(6):1497-1505
pubmed: 32088180
Crit Care. 2006;10(2):R41
pubmed: 16542488
Infect Control Hosp Epidemiol. 2020 Dec;41(12):1479-1482
pubmed: 32362292
Am J Respir Crit Care Med. 2020 Aug 15;202(4):624-626
pubmed: 32579022
Clin Rheumatol. 2020 Jul;39(7):2085-2094
pubmed: 32474885
Trials. 2020 Nov 11;21(1):919
pubmed: 33176850
Clin Immunol. 2020 Jun;215:108426
pubmed: 32311462
Am J Physiol Lung Cell Mol Physiol. 2020 Jul 1;319(1):L115-L120
pubmed: 32493030
J Perinatol. 2008 May;28 Suppl 1:S47-56
pubmed: 18446178
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
N Engl J Med. 2021 Feb 11;384(6):497-511
pubmed: 33264556
J Mol Med (Berl). 2020 Jun;98(6):789-803
pubmed: 32494931
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Arthritis Rheumatol. 2020 Jul;72(7):1059-1063
pubmed: 32293098
Arch Iran Med. 2020 Apr 01;23(4):255-264
pubmed: 32271599
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Arch Iran Med. 2020 Apr 01;23(4):216-219
pubmed: 32271593
Curr Pharmacol Rep. 2020 May 11;:1-15
pubmed: 32395418
Expert Rev Anti Infect Ther. 2020 Sep;18(9):843-847
pubmed: 32419524
Tohoku J Exp Med. 2020;252(1):73-84
pubmed: 32908083
Lancet Respir Med. 2020 Jul;8(7):717-725
pubmed: 32422180
BMC Pulm Med. 2019 Jan 9;19(1):9
pubmed: 30626363
Front Med (Lausanne). 2020 May 22;7:254
pubmed: 32574339
Nat Rev Drug Discov. 2020 Mar;19(3):149-150
pubmed: 32127666
Crit Care Clin. 2011 Jul;27(3):525-59
pubmed: 21742216
J Microbiol Immunol Infect. 2020 Jun;53(3):436-443
pubmed: 32307245
Infect Control Hosp Epidemiol. 2020 Jun;41(6):754-755
pubmed: 32192541
Chest. 2020 Apr;157(4):e99-e101
pubmed: 32087216
Lancet. 2020 Mar 28;395(10229):1035-1036
pubmed: 32199073
Clin Drug Investig. 2020 Jun;40(6):511-518
pubmed: 32337664
J Res Med Sci. 2020 Mar 30;25:32
pubmed: 32582338
Neonatology. 2017;111(4):408-414
pubmed: 28538236
Cell Death Differ. 2020 May;27(5):1451-1454
pubmed: 32205856
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD000141
pubmed: 19160177